Interferon beta for secondary progressive multiple sclerosis
L. La Mantia(University of Cagliari), Graziella Filippini(Oldham Council), S. Fredrikson(Karolinska Institutet), Laura Vacchi(Neuroscience Institute), George C. Ebers(John Radcliffe Hospital), Marco Rovaris(San Raffaele University of Rome), Carlo Di Pietrantonj(Azienda Sanitaria Locale Alessandria)
Cited by 94
Related Papers
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
|The Lancet|1998|2.1k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS
|DIAL (Catholic University of Leuven)|2001|472